Overview
Karisa Schreck is co-director of the BRAF Brain Tumor Center at Johns Hopkins. Her research focuses on the development of small-molecule targeted therapies for patients with primary brain tumors. Dr. Schreck has specific expertise in the treatment of BRAF gene mutations. As such, she works with Christine Pratilas’ laboratory to investigate resistance mechanisms to BRAF-targeted therapy. Dr. Schreck also writes and runs clinical trials for novel targeted agents through the Comprehensive Brain Tumor Center and the Alliance for Clinical Trials in Oncology.
Dr. Schreck is rated as an Experienced provider by MediFind in the treatment of Neurosarcoidosis. Her top areas of expertise are Glioma, Brain Tumor, Astrocytoma, and Glioblastoma.
Her clinical research consists of co-authoring 57 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Neurosarcoidosis.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Viragh BLDG 5th FL, Baltimore, MD 21287
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Johns Hopkins Outpatient Center
Dr. Barney J. Stern is a neurologist specializing in vascular neurology and neurological complications of sarcoidosis. His work in vascular neurology has covered all aspects of stroke management, including prevention and acute, subacute and chronic care. Dr. Stern also provides complex care management for patients suffering from neurosarcoidosis. His research focuses on understanding the biology and clinical outcomes of neurovascular disease and neurological complications associated with sarcoidosis. Dr. Stern has served as the medical safety monitor on a number of National Institutes of Health (NIH) stroke studies. In his new role at Johns Hopkins, Dr. Stern will be seeing outpatients as a member of the Advanced Clinical Neurology division with Dr. John Probasco. Dr. Stern is rated as a Distinguished provider by MediFind in the treatment of Neurosarcoidosis. His top areas of expertise are Neurosarcoidosis, Stroke, Herpes Zoster Oticus, Arachnoiditis, and Thrombectomy.
Johns Hopkins Outpatient Center
Dr. Pardo's interest in transverse myelitis centers on management of acute myelitis, biomarkers of the disease in cerebrospinal fluid (CSF) and blood, and the role of neuroimmune factors in the pathogenesis of myelopathies. Along with others neurologists and health care providers in the Johns Hopkins Transverse Myelitis Center, Dr. Pardo focuses on a comprehensive approach in the diagnosis and management of myelopathies, myelitis, neuroimmunological and neuroinfectious disorders. Dr. Pardo is rated as a Distinguished provider by MediFind in the treatment of Neurosarcoidosis. His top areas of expertise are Acute Flaccid Myelitis (AFM), Neurosarcoidosis, Transverse Myelitis, Zika Virus Disease, and Gastrostomy.
Johns Hopkins University
Peter Calabresi is a Neurologist in Baltimore, Maryland. Dr. Calabresi is rated as an Elite provider by MediFind in the treatment of Neurosarcoidosis. His top areas of expertise are Multiple Sclerosis (MS), Optic Neuritis, Relapsing Multiple Sclerosis (RMS), and CACH Syndrome.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- GliomaDr. Schreck isElite. Learn about Glioma.
- Distinguished
- AstrocytomaDr. Schreck isDistinguished. Learn about Astrocytoma.
- Atypical Teratoid Rhabdoid Tumor (ATRT)Dr. Schreck isDistinguished. Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).
- Brain TumorDr. Schreck isDistinguished. Learn about Brain Tumor.
- Embryonal Tumor with Multilayered RosettesDr. Schreck isDistinguished. Learn about Embryonal Tumor with Multilayered Rosettes.
- EpendymomaDr. Schreck isDistinguished. Learn about Ependymoma.
- GlioblastomaDr. Schreck isDistinguished. Learn about Glioblastoma.
- Advanced
- Metastatic Brain TumorDr. Schreck isAdvanced. Learn about Metastatic Brain Tumor.
- Posterior Fossa TumorDr. Schreck isAdvanced. Learn about Posterior Fossa Tumor.
- Primitive Neuroectodermal Tumor (PNET)
- Experienced
- Acute Cerebellar AtaxiaDr. Schreck isExperienced. Learn about Acute Cerebellar Ataxia.
- Brain Stem CancerDr. Schreck isExperienced. Learn about Brain Stem Cancer.
- Dysembryoplastic Neuroepithelial Tumors (DNET)
- MedulloblastomaDr. Schreck isExperienced. Learn about Medulloblastoma.
- NeurofibromatosisDr. Schreck isExperienced. Learn about Neurofibromatosis.
- Neurofibromatosis Type 2 (NF2)Dr. Schreck isExperienced. Learn about Neurofibromatosis Type 2 (NF2).